Puma Biotechnology (PBYI) Net Margin (2017 - 2026)
Puma Biotechnology (PBYI) reported Net Margin of 8.37% for Q1 2026, down 1484.0% on a YoY basis from 0.61% in Q1 2025, and down 137.88% quarter-over-quarter from 22.11% in Q4 2025.
Puma Biotechnology (PBYI) Net Margin (2017 - 2026) Analysis & Trends
Puma Biotechnology has reported Net Margin for 10 years, with the latest figure at 8.37% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin fell 1484.0% year-over-year to 8.37%; the trailing twelve-month figure through Mar 2026 stood at 12.16% (up 912.0% YoY), and the FY2025 full-year result was 15.04%, up 1536.0% from the prior year.
- Net Margin for Q1 2026 stood at 8.37%, down from 22.11% in the prior quarter.
- The five-year high for Net Margin was 25.23% in Q3 2024, with the low at 19.8% in Q4 2024.
- Historically, Net Margin has averaged 2.13% across 5 years, with a median of 2.65% in 2023.
- The largest YoY upside for Net Margin was 9597 bps in 2022 against a maximum downside of 2428 bps in 2022.
- Puma Biotechnology's Net Margin stood at 6.29% in 2022, then tumbled by 129 bps to 14.42% in 2023, then slumped by 37 bps to 19.8% in 2024, then surged by 212 bps to 22.11% in 2025, then sank by 138 bps to 8.37% in 2026.
- The last three Net Margin figures came in at 8.37% (Q1 2026), 22.11% (Q4 2025), and 16.23% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Puma Biotechnology | 384.39 Mn | 282.84 Mn | 34.39 Mn | -8.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.37% |
| Dec 31, 2025 | 22.11% |
| Sep 30, 2025 | 16.23% |
| Jun 30, 2025 | 11.17% |
| Mar 31, 2025 | 6.46% |
| Dec 31, 2024 | -19.80% |
| Sep 30, 2024 | 25.23% |
| Jun 30, 2024 | -9.62% |
| Mar 31, 2024 | -11.00% |
| Dec 31, 2023 | -14.42% |
| Sep 30, 2023 | 10.33% |
| Jun 30, 2023 | 3.90% |
| Mar 31, 2023 | 2.65% |
| Dec 31, 2022 | -6.29% |
| Sep 30, 2022 | -0.63% |
| Jun 30, 2022 | 15.74% |
| Mar 31, 2022 | -7.44% |
| Dec 31, 2021 | 7.63% |
| Sep 30, 2021 | -96.60% |
| Jun 30, 2021 | -9.56% |